Back to Search
MICHAEL DROLLER, M.D.
M.D.
Specialist
NPI: 1528061686IndividualAccepts Medicare
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
158347(NY)
CMS Specialties
PrimaryUROLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1968
Research & Publications (20)
Words of wisdom. Re: Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.
PMID 18061997·Eur Urol·2006
8-other
Biological considerations in the assessment of urothelial cancer: a retrospective.
PMID 16194710·Urology·2005
6-review
Primary care update on kidney and bladder cancer: a urologic perspective.
PMID 15049580·Med Clin North Am·2004
6-review
Maintenance therapy for superficial bladder cancer.
PMID 11354029·Oncology (Williston Park)·2001
8-other
Urology in the twenty-first century: noninvasive targeted treatments for urologic malignancies.
PMID 11071464·World J Surg·2000
6-review
Premalignant lesions and carcinoma in situ in bladder neoplasia: introduction and overview.
PMID 11144905·Scand J Urol Nephrol Suppl·2000
8-other
[Bladder cancer: understanding the disease and future implications for assessment and therapy].
PMID 17225686·Rev Med Suisse·2006
6-review
Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
PMID 18815934·Scand J Urol Nephrol Suppl·2008
6-review
Peer review of guidelines, best practice statements and new documents: what this means for how we use them.
PMID 18930290·J Urol·2008
8-other
Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
PMID 18815935·Scand J Urol Nephrol Suppl·2008
6-review
Bladder cancer: from pathogenesis to prevention.
PMID 18815911·Scand J Urol Nephrol Suppl·2008
8-other
A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
PMID 17499291·J Urol·2007
3-trial
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
PMID 17499283·J Urol·2007
3-trial
Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.
PMID 16809733·J Clin Oncol·2006
3-trial
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.
PMID 16399416·Urology·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 E 98TH ST, FL 6
NEW YORK, NY 10029 - Phone
- (212) 241-4812
Quick Facts
- NPI
- 1528061686
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 58
- Publications
- 20
Are you this provider?
Claim Your Profile